Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  L. Tao,et al.  Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis , 2021, Frontiers in Oncology.

[3]  K. Tao,et al.  Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile , 2021, Frontiers in Oncology.

[4]  A. Ginzac,et al.  Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study , 2021, Cancer medicine.

[5]  Yongqiang Wang,et al.  Fructose‐1,6‐Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis , 2021, Hepatology.

[6]  Takao Shimizu,et al.  Hepatic Levels of DHA-Containing Phospholipids Instruct SREBP1-Mediated Synthesis and Systemic Delivery of Polyunsaturated Fatty Acids , 2020, iScience.

[7]  Kun Wang,et al.  Calcium Sensing Receptor Inhibits Growth of Human Lung Adenocarcinoma Possibly via the GSK3β/Cyclin D1 Pathway , 2020, Frontiers in Cell and Developmental Biology.

[8]  Margaret H. Frank,et al.  TBtools - an integrative toolkit developed for interactive analyses of big biological data. , 2020, Molecular plant.

[9]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[10]  R. Figlin,et al.  The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) , 2019, Journal of Immunotherapy for Cancer.

[11]  S. Varambally,et al.  Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers , 2019, Nature Communications.

[12]  Zhipeng Wang,et al.  Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis , 2019, Cell transplantation.

[13]  Qing Zhou,et al.  Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis , 2019, Journal of cellular physiology.

[14]  B. Zhang,et al.  Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma , 2019, PeerJ.

[15]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[16]  Q. Cao,et al.  Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  J. Qiu,et al.  Accumulation of fructose 1,6-bisphosphate protects clear cell renal cell carcinoma from oxidative stress , 2019, Laboratory Investigation.

[18]  Erdal Kurnaz,et al.  Rare Cause of Infantile Hypercalcemia: A Novel Mutation in the SLC34A1 Gene , 2018, Hormone Research in Paediatrics.

[19]  M. Hsiao,et al.  Roles of Aldolase Family Genes in Human Cancers and Diseases , 2018, Trends in Endocrinology & Metabolism.

[20]  R. Uzzo,et al.  Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies , 2018, Molecular Cancer Therapeutics.

[21]  J. Vilo,et al.  MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. , 2018, Epigenomics.

[22]  Jing Wang,et al.  LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..

[23]  M. Zhu,et al.  Calcium Promotes Human Gastric Cancer via a Novel Coupling of Calcium-Sensing Receptor and TRPV4 Channel. , 2017, Cancer research.

[24]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[25]  J. Pankow,et al.  Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism , 2017, Scientific Reports.

[26]  F. Guo,et al.  CIRH1A augments the proliferation of RKO colorectal cancer cells. , 2017, Oncology reports.

[27]  Charles Swanton,et al.  Renal cell carcinoma , 2017, Nature Reviews Disease Primers.

[28]  E. V. Van Allen,et al.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures , 2016, Genome Biology.

[29]  Ludmila V. Danilova,et al.  Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures , 2016, Genome Biology.

[30]  M. Konrad,et al.  Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. , 2016, Journal of the American Society of Nephrology : JASN.

[31]  H. Kiyonari,et al.  Calcilytic Ameliorates Abnormalities of Mutant Calcium‐Sensing Receptor (CaSR) Knock‐In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH) , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  K. Giacomini,et al.  SLC transporters as therapeutic targets: emerging opportunities , 2015, Nature Reviews Drug Discovery.

[33]  F. Kortüm,et al.  Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome , 2015, Nature Genetics.

[34]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[35]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[36]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[37]  S. Rosenberg.  IL-2: The First Effective Immunotherapy for Human Cancer , 2014, The Journal of Immunology.

[38]  Weiwei Guo,et al.  De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome , 2014, Cell Research.

[39]  K. Junker,et al.  High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor , 2014, Molecular Cancer.

[40]  R. Thakker,et al.  Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[41]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[42]  Zhiwei Song.  Roles of the nucleotide sugar transporters (SLC35 family) in health and disease. , 2013, Molecular aspects of medicine.

[43]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[44]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[45]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[46]  K. Beyenbach,et al.  The V-type H+ ATPase: molecular structure and function, physiological roles and regulation , 2006, Journal of Experimental Biology.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[48]  T. Hudson,et al.  A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. , 2002, American journal of human genetics.

[49]  S. Maeda,et al.  What patients can survive disease free after complete resection for hepatocellular carcinoma?: A multivariate analysis. , 2000, Japanese journal of clinical oncology.

[50]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[51]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[52]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.